Xavier Morge

Xavier Morge started their work experience in 1991 as the Managing Director at SPI-BIO. Xavier then worked as the Managing Director at several subsidiary companies of Bertin, including Ellipse Pharmaceuticals SAS, Biotec Centre SAS, and IDPS. In 2010, they became the Managing Director of Bertin Pharma and held this position until 2017. From 2017 to 2020, they served as the Chief Business Development & Marketing Officer at Oncodesign. Currently, Xavier Morge is the CEO of BIOASTER, starting in December 2020.

Xavier Morge completed their Doctor of Pharmacy - PharmD degree at Paris-Sud University (Paris XI) from 1982 to 1989. Later, from 1993 to 1995, they pursued a Master of Business Administration (MBA) degree from IAE Paris (Sorbonnes).